1. Home
  2. ESGL vs BYSI Comparison

ESGL vs BYSI Comparison

Compare ESGL & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESGL
  • BYSI
  • Stock Information
  • Founded
  • ESGL 1999
  • BYSI 2010
  • Country
  • ESGL Singapore
  • BYSI United States
  • Employees
  • ESGL N/A
  • BYSI N/A
  • Industry
  • ESGL
  • BYSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESGL
  • BYSI Health Care
  • Exchange
  • ESGL Nasdaq
  • BYSI Nasdaq
  • Market Cap
  • ESGL 64.6M
  • BYSI 72.1M
  • IPO Year
  • ESGL N/A
  • BYSI 2017
  • Fundamental
  • Price
  • ESGL $2.00
  • BYSI $1.62
  • Analyst Decision
  • ESGL
  • BYSI
  • Analyst Count
  • ESGL 0
  • BYSI 0
  • Target Price
  • ESGL N/A
  • BYSI N/A
  • AVG Volume (30 Days)
  • ESGL 55.9K
  • BYSI 14.0K
  • Earning Date
  • ESGL 04-08-2025
  • BYSI 01-01-0001
  • Dividend Yield
  • ESGL N/A
  • BYSI N/A
  • EPS Growth
  • ESGL N/A
  • BYSI N/A
  • EPS
  • ESGL N/A
  • BYSI N/A
  • Revenue
  • ESGL $6,264,048.00
  • BYSI N/A
  • Revenue This Year
  • ESGL N/A
  • BYSI N/A
  • Revenue Next Year
  • ESGL N/A
  • BYSI N/A
  • P/E Ratio
  • ESGL N/A
  • BYSI N/A
  • Revenue Growth
  • ESGL 12.87
  • BYSI N/A
  • 52 Week Low
  • ESGL $0.42
  • BYSI $1.37
  • 52 Week High
  • ESGL $3.00
  • BYSI $3.63
  • Technical
  • Relative Strength Index (RSI)
  • ESGL 61.95
  • BYSI 49.64
  • Support Level
  • ESGL $1.86
  • BYSI $1.37
  • Resistance Level
  • ESGL $2.05
  • BYSI $1.65
  • Average True Range (ATR)
  • ESGL 0.15
  • BYSI 0.12
  • MACD
  • ESGL -0.01
  • BYSI -0.01
  • Stochastic Oscillator
  • ESGL 81.94
  • BYSI 53.19

About ESGL ESGL Holdings Limited

ESGL Holdings Ltd Formerly Environmental Solutions Group Holdings Ltd is a waste management, treatment and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical and electroplating companies.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.

Share on Social Networks: